GEODE CAPITAL MANAGEMENT, LLC

Position in INBX — Inhibrx Biosciences, Inc.

CIK 1214717 BOSTON, MA

Position in INBX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$24,272,580

+$8,708,231 QoQ

Shares Held

256,175

+10.7% QoQ

Ownership

1.74%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#18

of 161 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,515,789 across 520 Biotechnology names. INBX ranks #119 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$24,272,580	256,175	+10.7%	Shares	Defined	2026-08-12
2026-03-31	$15,564,349	231,509	+2.4%	Shares	Defined	2026-05-15
2025-12-31	$17,854,711	226,009	+1.8%	Shares	Defined	2026-02-09
2025-09-30	$7,474,265	221,920	-1.8%	Shares	Defined	2025-11-12
2025-06-30	$3,224,377	225,955	-13.1%	Shares	Defined	2025-08-08
2025-03-31	$3,637,804	260,029	+1.9%	Shares	Defined	2025-05-13
2024-12-31	$3,929,047	255,133	+1.6%	Shares	Defined	2025-02-12
2024-09-30	$3,934,089	251,219	+19.4%	Shares	Defined	2024-11-12
2024-06-30	$2,980,190	210,317	—	Shares	Defined	2024-08-09
No filing history on record for this holder in this stock.